Australian Clinical Labs Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	26.31	32.43	23.93	35.9	178.24	60.37
Depreciation & Amortization	134.93	136.04	128.43	122.76	106.1	88.05
Loss (Gain) From Sale of Assets	0.04	0.04	1.04	-0.14	0.67	-0.03
Stock-Based Compensation	3.44	3.44	3.06	1.88	1.46	2.17
Other Operating Activities	-9.61	1.38	2.64	-10.48	8.14	-9.71
Change in Accounts Receivable	8.32	8.32	-7.72	17.4	-28.12	2.75
Change in Inventory	1.21	1.21	-1.73	5	-3.9	-2.26
Change in Accounts Payable	-0.03	-0.03	11.65	-17.73	16.49	5.18
Change in Other Net Operating Assets	-0.04	-0.04	-1.71	-10.91	5.01	7.34
Operating Cash Flow	164.57	182.8	159.59	143.68	284.09	153.86
Operating Cash Flow Growth	-1.54%	14.54%	11.07%	-49.42%	84.64%	51.24%
Capital Expenditures	-7.88	-8.41	-6.51	-6.93	-21.25	-9.51
Sale of Property, Plant & Equipment	0.14	0.1	0.33	0.24	0.27	0.11
Cash Acquisitions	-0.58	-0.58	-1.07	-5.48	-51.06	2.25
Investment in Securities	-	-	-	-	-	1.07
Investing Cash Flow	-8.32	-8.9	-7.25	-12.18	-72.04	-6.08
Long-Term Debt Issued	-	31	14	100.5	-	321.6
Total Debt Issued	40	31	14	100.5	-	321.6
Long-Term Debt Repaid	-	-165.68	-138.06	-140.61	-191.69	-357.22
Total Debt Repaid	-145.25	-165.68	-138.06	-140.61	-191.69	-357.22
Net Debt Issued (Repaid)	-105.25	-134.68	-124.06	-40.11	-191.69	-35.62
Issuance of Common Stock	-	-	-	-	-	146.25
Repurchase of Common Stock	-24.68	-19.12	-1.74	-0.89	-4.94	-
Common Dividends Paid	-24.42	-24.95	-19.95	-96.88	-24.22	-42
Other Financing Activities	-0.31	-	-0.39	-	-0.06	-216
Financing Cash Flow	-154.65	-178.74	-146.14	-137.88	-220.91	-147.37
Foreign Exchange Rate Adjustments	0.02	0.14	-0.03	-0.04	0.01	-0.03
Net Cash Flow	1.62	-4.69	6.18	-6.42	-8.86	0.38
Free Cash Flow	156.7	174.39	153.09	136.75	262.84	144.36
Free Cash Flow Growth	-2.35%	13.92%	11.95%	-47.97%	82.07%	56.31%
Free Cash Flow Margin	21.25%	23.53%	21.98%	19.62%	26.40%	22.32%
Free Cash Flow Per Share	0.84	0.92	0.77	0.68	1.30	0.95
Cash Interest Paid	17.52	18.46	16.67	13.85	11.39	39.39
Cash Income Tax Paid	21.61	14.43	10.16	17.91	68.87	18.56
Levered Free Cash Flow	168.14	178.08	161.24	126.48	250.39	170.88
Unlevered Free Cash Flow	177.13	187.2	168.85	134.9	257.74	180.34
Change in Working Capital	9.46	9.46	0.49	-6.24	-10.52	13

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.